YCM
INDV icon

Yousif Capital Management’s Indivior Pharmaceuticals INDV Stock Holding History

Yousif Capital Management’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.38M Sell
33,648
-234
-0.7% -$8.49K 0.02% 865
2026
Q1 		$1.03M Sell
33,882
-615
-2% -$20.3K 0.01% 1036
2025
Q4 		$1.14M Buy
+34,497
New +$1.05M 0.01% 1018

Other funds holding INDV

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
LSERS
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
SOADOR
State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
MAG
MRA Advisory Group Parsippany, New Jersey $276M AUM 31.26% 1-Year Est. Return

Yousif Capital Management's INDV Position: Q2 2026 in Review

Yousif Capital Management reduced its Indivior Pharmaceuticals (INDV) stake by 0.69% in Q2 2026, selling an estimated $8.49K and leaving 33,648 shares worth $1.38M. The position accounts for 0.02% of the portfolio, ranked #865.

Yousif Capital Management first reported a position in INDV in Q4 2025 and has held it in 3 quarters since. 31 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

  • Yousif Capital Management held 33,648 shares of Indivior Pharmaceuticals worth $1.38M as of Q2 2026.
  • Yousif Capital Management sold 234 Indivior Pharmaceuticals shares in Q2 2026, an estimated $8.49K.
  • Indivior Pharmaceuticals made up 0.02% of Yousif Capital Management's portfolio in Q2 2026, its #865 holding.
  • Yousif Capital Management first reported a position in Indivior Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 31 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on Yousif Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.